Phase I/II trial of the safety and efficacy of AE-941 (Neovastat) in the treatment of non-small-cell lung cancer.

Jean Latreille; Gerald Batist; Francis Laberge; Pierre Champagne; Daniel Croteau; Pierre Falardeau; Carey Levinton; Claude Hariton; William K Evans; Eric Dupont

doi:10.3816/clc.2003.n.003

Phase I/II trial of the safety and efficacy of AE-941 (Neovastat) in the treatment of non-small-cell lung cancer.

Identifier:nobleid.org/w1/20260515/F2FBA943

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/F2FBA943.svg?ark=w1%2F20260515%2FF2FBA943)](https://nobleid.org/work/w1/20260515/F2FBA943)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work

Phase I/II trial of the safety and efficacy of AE-941 (Neovastat) in the treatment of non-small-cell lung cancer.

Identifier:nobleid.org/w1/20260515/F2FBA943

Type:Journal Article

0 views

Support unavailableClaim Your Authorship

Embeddable Badge

[![NobleID](https://www.nobleid.org/api/badge/F2FBA943.svg?ark=w1%2F20260515%2FF2FBA943)](https://nobleid.org/work/w1/20260515/F2FBA943)

ARK Inflections

Metadata Policy

Metadata Formats

Bibliometric Analysis

Impact metrics, research fronts, co-authorship networks →

Authors & Claims

Paper Authors

Claim authorship of this work